Scientific Sessions 2024  /  Hot Debates in Heart Failure  /  CRISPR Clarity: The Time is Now for Gene Editing in Cardiomyopathy
Logo

American Heart Association

  2
  0

Final ID:

CRISPR Clarity: The Time is Now for Gene Editing in Cardiomyopathy

  • Musunuru, Kiran  ( Perelman School of Medicine , Philadelphia , Pennsylvania , United States )
  • Olson, Eric  ( UNIV TEXAS SOUTHWESTERN MED CTR , Dallas , Texas , United States )
    • Author Disclosures:
    Kiran Musunuru: DO have relevant financial relationships ; Advisor:Verve Therapeutics:Active (exists now) ; Advisor:Capstan Therapeutics:Active (exists now) ; Advisor:LEXEO Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Beam Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Nava Therapeutics:Active (exists now) ; Ownership Interest:Variant Bio:Active (exists now) ; Individual Stocks/Stock Options:Verve Therapeutics:Active (exists now) | Eric Olson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Hot Debates in Heart Failure

Monday, 11/18/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Preventing Stage C Begins with Stage B

Patel Kershaw, Ndumele Chiadi

CON: Lightening the Load: Use of GLP-1 Receptor Agonists in Heart Failure

Nazha Hamdani, Butler Javed

More abstracts from these authors:
Follow the white rabbit: The power of informatics to identify inherited disorders

Pepplinkhuizen Shari, Khera Amit, Musunuru Kiran

You have to be authorized to contact abstract author. Please, Login
Not Available